Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous Cell Cancers of the Head and Neck × Afatinib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 2 Squamous Cell Cancers of the Head and Neck 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Cholangiocarcinoma 1

Interventions

Cetuximab 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02979977 2026-02-04

Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck

Yale University

Phase 2 Completed

50 enrolled 14 charts

Squamous Cell Cancers of the Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡